Trial details
Feasibility of Integrating Rectal Hydrogel Spacer for Salvage Treatment using STereotactic Ablative Body Radiotherapy for Locally Recurrent Prostate Cancer (FIRST STAR)
To find out more about this trial and your cancer treatment options, please speak with your doctor.
Trial short name: FIRST STAR
Official title: Feasibility of Integrating Rectal Hydrogel Spacer for Salvage Treatment using STereotactic Ablative Body Radiotherapy for Locally Recurrent Prostate Cancer (FIRST STAR)
Principal Investigator: Dr. Andrew Loblaw
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase:
Intervention:
Registration #:
Contact e-mail: cancerclinicaltrials@sunnybrook.ca
